|Articles|September 18, 2020
Accelerating the Development of Orphan Drugs for Rare Diseases
Author(s)Quotient Sciences
This white paper addresses the principal CMC challenges for the developers of orphan drugs and highlights the potential solutions which are emerging.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
FDA Activity Round Up – July 2026
2
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
3
Midyear 2026 Check-In: AI, Supply Chains, and the NDC-12 Story Nobody's Watching
4
From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026
5